Enlivex Therapeutics (ENLV) Earnings Date & Reports

Industry: @Medical Specialties

A.I. Advisor

published Earnings

ENLV is expected to report earnings to fall 12.00% to -21 cents per share on August 26

Enlivex Therapeutics ENLV Stock Earnings Reports

Q2'24

Est.

$-0.22

Q1'24

Est.

$-0.25

Q4'23

Missed

by $0.21

Q3'23

Est.

$-0.32

Q2'23

Beat

by $0.06

The last earnings report on May 24 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 196.61K shares outstanding, the current market capitalization sits at 35.11M.

View a ticker or compare two or three

Compare

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

14 Einstein Street

Phone

+972 26208072

Employees

Web

https://www.enlivex.com